tetano
Editor, Senior Moderator
Pediatr Dermatol
. 2022 Aug 30.
doi: 10.1111/pde.15122. Online ahead of print.
Reactive infectious mucocutaneous eruption following COVID-19 in an adolescent boy: Case report and review of the literature
Ayisha Mahama[SUP] 1 [/SUP], Priscilla Kojder[SUP] 2 [/SUP], Quinn Thibodeaux[SUP] 2 [/SUP], Jennifer Ruth[SUP] 3 [/SUP]
Affiliations
Abstract
Reactive infectious mucocutaneous eruption (RIME) is a mucosal-predominant eruption that usually affects two or more mucosal sites. We present a case of RIME secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and provide a brief review of the literature with a focus on the natural history and response to treatment. This entity may require inpatient management and systemic corticosteroids for symptom control in the pediatric population.
Keywords: COVID-19; SARS-CoV-2; exanthema; mucositis; prednisone.
. 2022 Aug 30.
doi: 10.1111/pde.15122. Online ahead of print.
Reactive infectious mucocutaneous eruption following COVID-19 in an adolescent boy: Case report and review of the literature
Ayisha Mahama[SUP] 1 [/SUP], Priscilla Kojder[SUP] 2 [/SUP], Quinn Thibodeaux[SUP] 2 [/SUP], Jennifer Ruth[SUP] 3 [/SUP]
Affiliations
- PMID: 36042536
- DOI: 10.1111/pde.15122
Abstract
Reactive infectious mucocutaneous eruption (RIME) is a mucosal-predominant eruption that usually affects two or more mucosal sites. We present a case of RIME secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and provide a brief review of the literature with a focus on the natural history and response to treatment. This entity may require inpatient management and systemic corticosteroids for symptom control in the pediatric population.
Keywords: COVID-19; SARS-CoV-2; exanthema; mucositis; prednisone.